Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

270,636 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical outcomes of second-line treatment following first-line VEGFR-TKI failure in patients with metastatic renal cell carcinoma: a comparison of axitinib alone and axitinib plus anti-PD-1 antibody.
Huang J, Wang Y, Zhang H, Hu X, Wang P, Cai W, Yuan Y, Zeng H, Zhang J, Kong W, Huang Y, Wang S, Guo J, Wei Q, Xue W. Huang J, et al. Among authors: wang y, wang p, wang s. Cancer Commun (Lond). 2021 Oct;41(10):1071-1074. doi: 10.1002/cac2.12206. Epub 2021 Aug 7. Cancer Commun (Lond). 2021. PMID: 34363742 Free PMC article. No abstract available.
Special issue "The advance of solid tumor research in China": Presurgical therapy in the management of local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy.
Wang Y, Huang J, Zhang C, Hu X, Wang P, Shi G, Zhang J, Kong W, Chen Y, Huang Y, Ye D, Xia D, Guo J, He Z, Xue W. Wang Y, et al. Among authors: wang p. Int J Cancer. 2023 Jan 1;152(1):24-30. doi: 10.1002/ijc.34173. Epub 2022 Jun 29. Int J Cancer. 2023. PMID: 35712762 Free article.
270,636 results
You have reached the last available page of results. Please see the User Guide for more information.